Jia Ruan, MD, PhD

Videos

Diagnosis and Risk Stratification of Mantle Cell Lymphoma: Part 1

11/03/2023

In the first part of an expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD, on the diagnostics and risk stratification of mantle cell lymphoma.

In the first part of an expert...

11/03/2023

Oncology

Videos

Role of Non-Covalent BTK Inhibitors in Mantle Cell Lymphoma Treatment: Part 4

11/13/2023

Jia Ruan , MD, PhD;

Kami J. Maddocks , MD;

Krish Patel , MD;

Kami Maddocks, MD, discusses the role of non-covalent BTK inhibitors in the treatment of patients with mantle cell lymphoma with Jia Ruan, MD, PhD, and Krish Patel, MD.

Kami Maddocks, MD, discusses the...

11/13/2023

Oncology

Videos

Treating Patients With Relapsed/Refractory Mantle Cell Lymphoma: Part 3

11/13/2023

Jia Ruan , MD, PhD;

Kami J. Maddocks , MD;

Krish Patel , MD;

In this expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD on the best options for treating patients with relapsed/refractory mantle cell lymphoma.

In this expert roundtable...

11/13/2023

Oncology

Videos

Approaches to Frontline Therapy for Patients With Mantle Cell Lymphoma: Part 2

11/09/2023

Jia Ruan , MD, PhD;

Kami J. Maddocks , MD;

Krish Patel , MD;

In the second part of an expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD on goals and choice of frontline therapy for patients with mantle cell lymphoma.

In the second part of an expert...

11/09/2023

Oncology

Videos

Evaluating Prognostic Factors for Mantle Cell Lymphoma

11/15/2023

Jia Ruan , MD, PhD;

Jia Ruan, MD, PhD, discusses important factors to consider in determining mantle cell lymphoma prognosis, including the utilization of measurement tools like MIPI and genetic mutation profile data.

Jia Ruan, MD, PhD, discusses...

11/15/2023

Oncology

Videos

Long-Term Updates on Chemotherapy-Free Lenalidomide Plus Rituximab Treatment for MCL

11/03/2023

Jia Ruan , MD, PhD;

Jia Ruan, MD, PhD, shares 9-year follow-up findings from a phase 2 trial on the outcomes of chemotherapy-free lenalidomide plus rituximab combination therapy among patients with mantle cell lymphoma.

Jia Ruan, MD, PhD, shares 9-year...

11/03/2023

Oncology

Videos

New Possibilities and Advances in Mantle Cell Lymphoma Treatment: Part 5

11/13/2023

Jia Ruan , MD, PhD;

Kami J. Maddocks , MD;

Krish Patel , MD;

Kami Maddocks, MD, reviews new possibilities and the latest advances in the treatment of patients with mantle cell lymphoma with Jia Ruan, MD, PhD, and Krish Patel, MD.

Kami Maddocks, MD, reviews new...

11/13/2023

Oncology

Conference Coverage

Evaluating Chemo-Free Novel Agent Combination Therapies for Mantle Cell Lymphoma

03/01/2024

Jia Ruan , MD, PhD;

At the Lymphoma, Leukemia & Myeloma Congress, Jia Ruan, MD, PhD, discusses the introduction of chemotherapy-free novel agents for the treatment of patients with mantle cell lymphoma.

At the Lymphoma, Leukemia &...

03/01/2024

Lymphoma, Leukemia & Myeloma Network